You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Last Updated: November 28, 2023

CLINICAL TRIALS PROFILE FOR LOTEPREDNOL ETABONATE; TOBRAMYCIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Loteprednol Etabonate; Tobramycin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00420628 ↗	Pediatric Zylet Safety and Efficacy Study	Completed	Bausch & Lomb Incorporated	Phase 4	2006-11-01	A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)
NCT00447577 ↗	Zylet vs TobraDex in Blepharokeratoconjunctivitis	Completed	Bausch & Lomb Incorporated	Phase 4	2007-01-01	The objective of this study is to evaluate the safety and efficacy of Zylet vs. Tobradex in the treatment of ocular inflammation associated with blepharokeratoconjunctivitis
NCT00834171 ↗	A Retrospective Evaluation of the Intraocular Pressure Spikes With Loteprednol and Loteprednol/Tobramycin	Completed	Allergan		2009-01-01	Patient charts will be reviewed to evaluate the incidence of intraocular pressure spikes while on Loteprednol etabonate ophthalmic suspension 0.5%, Loteprednol etabonate (0.5%) and tobramycin (0.3%)
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Loteprednol Etabonate; Tobramycin

Condition Name

Chart
Table

Condition Name for Loteprednol Etabonate; Tobramycin
Intervention	Trials
Vernal Keratoconjunctivitis	2
Chalazion	1
Conjunctivitis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Loteprednol Etabonate; Tobramycin
Intervention	Trials
Keratoconjunctivitis	2
Conjunctivitis, Allergic	2
Ocular Hypertension	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Loteprednol Etabonate; Tobramycin

Trials by Country

Map
Table

Trials by Country for Loteprednol Etabonate; Tobramycin
Location	Trials
United States	4
Singapore	1
China	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Loteprednol Etabonate; Tobramycin
Location	Trials
New York	1
Virginia	1
North Carolina	1
Pennsylvania	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Loteprednol Etabonate; Tobramycin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Loteprednol Etabonate; Tobramycin
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	1
Phase 1	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Loteprednol Etabonate; Tobramycin
Clinical Trial Phase	Trials
Completed	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Loteprednol Etabonate; Tobramycin

Sponsor Name

Chart
Table

Sponsor Name for Loteprednol Etabonate; Tobramycin
Sponsor	Trials
Bausch & Lomb Incorporated	4
Allergan	1
Zhongshan Ophthalmic Center, Sun Yat-sen University	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Loteprednol Etabonate; Tobramycin
Sponsor	Trials
Industry	5
Other	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School

Mallinckrodt

Medtronic

Express Scripts

Merck

Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.